Novasep, a products and services provider focused on the design, manufacture and control of resin-based batch and continuous chromatography systems will work with Sartorius Stedim to introduce new membrane technology into its applications.
Kathryn Schnorf, head of product management, chromatography and virus, at Sartorius, told us,
“Chromatography remains the workhorse of downstream processing in the development and production of modern biopharmaceuticals. Purification by chromatography is essential for the manufacture of safe biopharmaceutical therapies in the required amounts and time.”
Per the collaboration, Novasep’s BioSC platform and Sartorius’ single-use technology will form the basis for the development of chromatography systems to provide an alternative to batch and continuous resin-based chromatography for smaller scale operations.
“While membranes or resins are at the ‘heart’ of the separation process, a well-designed chromatography system is absolutely necessary for efficient operation of the technology,” said Schnorf.
This partnership boosts Sartorius’ global product strategy to supply innovations for upstream and downstream processing equipment.
According to Sartorius, chromatography systems currently on the market do not take full advantage of the capabilities and benefits, or are designed to optimize operation.
